Home > Income Statement > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Revenue

    Back to Income Statement
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹581 Cr₹510 Cr₹472 Cr₹424 Cr₹386 Cr

What is the latest Revenue of LINCOLN PHARMACEUTICALS ?

The latest Revenue ratio of LINCOLN PHARMACEUTICALS is ₹581 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹581 Cr
Mar2024₹510 Cr
Mar2023₹472 Cr
Mar2022₹424 Cr
Mar2021₹386 Cr

How is Revenue of LINCOLN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹581 Cr
13.76
Mar2024 ₹510 Cr
8.09
Mar2023 ₹472 Cr
11.30
Mar2022 ₹424 Cr
9.75
Mar2021 ₹386 Cr -

Compare Revenue of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,147.3 Cr -2.1% -7.2% 11.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,495.0 Cr -5.7% -3.3% -2.1% Stock Analytics
DIVIS LABORATORIES ₹154,244.0 Cr -3.1% -9.3% 0% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,634.0 Cr -6.1% -8.3% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,594.0 Cr -5.1% -6% 4.8% Stock Analytics
CIPLA ₹97,022.8 Cr -3.3% -11.2% -19.5% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-2.1%

-7.2%

11.5%

SENSEX

-1.6%

-8.8%

-4.1%


You may also like the below Video Courses